SKIN & AESTHETICS / FAQ
Questions From the Literature
Direct, citation-anchored answers to the questions readers bring most often to these two skin-biology peptides.
What is Melanotan 2?
Melanotan 2 (also written Melanotan II or MT-2) is a synthetic cyclic heptapeptide — seven amino acids in a ring-closed structure — designed as a more potent, more stable analog of alpha-melanocyte-stimulating hormone (alpha-MSH). It was developed at the University of Arizona in the late 1980s with the goal of producing skin darkening at lower doses and without UV exposure [4]. It is a research chemical, not an approved drug, and its development did not progress past small Phase I studies [4][6].
What is Melanotan 2 used for in research?
In published research Melanotan II has been studied for three main things. First, skin pigmentation — Phase I work showed it could increase skin color without sun in two of three healthy volunteers [6]. Second, erectile function — a controlled crossover study documented erections in 8 of 10 men with psychogenic erectile dysfunction [5]. Third, in animal models, appetite regulation — microinjection into the nucleus accumbens reduced food intake and food-seeking behavior in mice without conditioning aversion [2]. No Phase II or Phase III clinical trial has been completed for any of these indications [4].
How does Melanotan 2 work in the body?
Melanotan II is a non-selective agonist at all five melanocortin receptors (MC1R through MC5R). For pigmentation: binding MC1R on melanocytes raises intracellular cAMP, activates the PKA-CREB-MITF cascade, upregulates tyrosinase, and shifts pigment production toward the darker eumelanin — producing darkening without UV [6]. For erections: MC4R (and MC3R) activation in hypothalamic and mesolimbic circuits drives pro-erectile signaling, as documented in controlled human work [5]. For appetite: MC4R and MC3R activation in the nucleus accumbens reduces food motivation [2]. The breadth of receptor activity is also the source of its cardiovascular, gastrointestinal and sebaceous-gland side effects.
What is the melanogenesis (MC1R-cAMP-MITF) signaling cascade?
Melanogenesis — the making of melanin pigment — follows a defined signaling sequence inside a melanocyte. An agonist such as Melanotan II binds the MC1R receptor on the cell surface, which activates adenylyl cyclase and raises the second-messenger cAMP. High cAMP activates protein kinase A (PKA), which phosphorylates the transcription factor CREB. Active CREB upregulates the master regulator of melanocyte identity and pigment production, MITF. MITF then turns on tyrosinase and the enzymes downstream of it (TYRP1, DCT/TYRP2), which catalyze the conversion of tyrosine first to DOPA and then to the eumelanin polymer. The end result is more pigment, shifted toward the darker brown-black form [6]. This is the same cascade that UV light triggers — Melanotan II shortcircuits the upstream part and activates the receptor directly.
Is Melanotan 2 safe?
The honest answer is that its safety profile in humans is incompletely characterized and includes documented serious adverse events. The Phase I studies in the 1990s showed manageable nausea, flushing and spontaneous erections but were in single-digit numbers of participants over short periods [5][6]. Since then, case reports have documented renal infarction [3], rhabdomyolysis, priapism, eruptive and dysplastic nevi, melanoma, and posterior reversible encephalopathy syndrome in melanotan users. Analytical studies of online products confirm contamination, mislabeling and variable content. Melanotan II is not approved anywhere, its long-term safety is unknown, and regulators in multiple countries have issued specific warnings against it. This site does not advise on human use.
Is Melanotan 2 the same as afamelanotide or bremelanotide?
No. All three are melanocortin peptides but they are distinct compounds. Afamelanotide (sometimes called Melanotan I) is a linear analog of alpha-MSH with a different sequence that has been approved for the rare disease erythropoietic protoporphyria. Bremelanotide is a shorter cyclic analog derived from Melanotan II that has a separate approval for hypoactive sexual desire disorder in premenopausal women. Melanotan II itself has no approval from any regulatory body for any indication [4]. The approved compounds' safety and efficacy data do not extend to Melanotan II.
What does a GHK-Cu peptide do?
GHK-Cu does two things at once. As a copper chaperone it delivers copper ion where it is needed for enzymatic cross-linking of collagen and elastin. As a signaling molecule it tells dermal fibroblasts to synthesize collagen, elastin, glycosaminoglycans and the proteoglycan decorin, while rebalancing the matrix metalloproteinases that break matrix down against their inhibitors [11]. At the gene level, an analysis reported that it shifts expression of roughly 31.2% of human genes (at a 50%-or-greater threshold) toward tissue-repair, protein-quality-control, DNA-repair and antioxidant programs [9]. In human topical studies, it increased collagen production in about 70% of treated subjects [11].
What is GHK-Cu and how does it work?
GHK-Cu is a linear tripeptide (glycyl-L-histidyl-L-lysine) chelated one-to-one to a copper(II) ion. The copper is held by the histidine ring and backbone nitrogen, leaving the lysine chain free. The same GHK sequence appears endogenously within type I collagen and the matrix protein SPARC/osteonectin [11]. Copper coordination is required for most reported bioactivities — it enables lysyl oxidase-mediated cross-linking of collagen and elastin fibers and supports the peptide's antioxidant activity. Without copper, the bare GHK peptide is substantially less active. This distinction matters because the two are frequently conflated in secondary sources.
Is GHK-Cu peptide really anti-aging?
There is real, if modest and mostly topical, evidence for skin-related benefits. Controlled clinical comparisons found topical GHK-Cu increased collagen production in 70% of treated women, outperforming vitamin C (50%) and retinoic acid (40%) in the same set, with documented improvements in skin laxity, fine lines and wrinkle depth [11]. The 45-patient hair-loss RCT found statistically significant hair count increases versus placebo [10]. Two honest limitations: the widely repeated "approximately 4,000 genes" figure is an extrapolation from a measured 31.2% at the 50%-threshold, which covers on the order of 2,100 genes [9]; and GHK-Cu penetrates intact skin poorly without delivery aids, limiting how much of a topical dose actually reaches the dermis [8]. Systemic "anti-aging" use is unproven in humans.
What is the difference between GHK and GHK-Cu?
GHK is the bare tripeptide glycyl-histidyl-lysine; GHK-Cu is that tripeptide chelated to a copper(II) ion. Copper coordination is required for most reported bioactivities, so the form present in a given study matters — the two are not interchangeable, and conflating them leads to misattribution of effects [11]. In practice, when research describes collagen stimulation, lysyl-oxidase-mediated fiber cross-linking and the antioxidant action, it is the copper complex at work. The bare tripeptide alone lacks the catalytic copper needed for those downstream steps.
Do Melanotan II and GHK-Cu work on the same skin targets?
No. They act on entirely different cell types and pathways. Melanotan II activates MC1R on melanocytes — the cells that make pigment — driving the PKA-MITF-tyrosinase cascade that shifts eumelanin production [6]. GHK-Cu signals dermal fibroblasts — the cells that build collagen and elastin — with no direct melanogenic mechanism [11]. One works at the surface pigment level; the other works in the deeper connective tissue. Their combined interests in skin are complementary but mechanistically separate. See the compare page for the full side-by-side.
Are these peptides approved drugs?
Neither is an approved medicine for systemic use. GHK-Cu's topical form (copper tripeptide-1) is a legal cosmetic ingredient in the US, EU and UK with a long market history [8]. Injectable or systemic GHK-Cu is unapproved and research-only. Melanotan II has no approval from any regulatory body for any indication — not for tanning, not for erectile dysfunction, not for anything [4]. Development did not progress past Phase I. Melanotan II is additionally prohibited in sport at all times under WADA's S0 Non-Approved Substances category.